Application 208855
- Type
- NDA
- Sponsor
- ELI LILLY AND CO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VERZENIO | ABEMACICLIB | TABLET;ORAL | 50MG | Yes | No |
| 002 | VERZENIO | ABEMACICLIB | TABLET;ORAL | 100MG | Yes | No |
| 003 | VERZENIO | ABEMACICLIB | TABLET;ORAL | 150MG | Yes | No |
| 004 | VERZENIO | ABEMACICLIB | TABLET;ORAL | 200MG | Yes | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.